Genetic variation in apolipoprotein D and Alzheimer’s disease

Author： Helisalmi S.   Hiltunen M.   Vepsäläinen S.   Iivonen S.   Corder E.   Lehtovirta M.   Mannermaa A.   Koivisto A.   Soininen H.  

Publisher： Springer Publishing Company

ISSN： 0340-5354

Source： Journal of Neurology, Vol.251, Iss.8, 2004-08, pp. : 951-957

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease

By Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 181-188

Humana Press, Inc

Access to resources Recommend Favorite

Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease

By Edland Steven  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 213-217

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite

Lipid profile factors and apolipoprotein E polymorphism in Alzheimer’s disease

By Helisalmi Seppo  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-27

Future Medicine

Access to resources Recommend Favorite